{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:11:17Z","timestamp":1792714277716,"version":"4.5.0"},"reference-count":110,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T00:00:00Z","timestamp":1732233600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T00:00:00Z","timestamp":1732233600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012397","name":"Army Medical University","doi-asserted-by":"crossref","award":["2018XLC3042"],"award-info":[{"award-number":["2018XLC3042"]}],"id":[{"id":"10.13039\/501100012397","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-024-03020-3","type":"journal-article","created":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T11:54:56Z","timestamp":1732276496000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Radionuclide-labelled nanoparticles for cancer combination therapy: a review"],"prefix":"10.1186","volume":"22","author":[{"given":"Na","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,22]]},"reference":[{"issue":"9","key":"3020_CR1","first-page":"1300","volume":"9","author":"F Luca","year":"2018","unstructured":"Luca F. Salomone, salvatore libra, massimo, evolution of cancer pharmacological treatments at the turn of the third millennium. Front Pharmacol. 2018;9(9):1300.","journal-title":"Front Pharmacol"},{"key":"3020_CR2","doi-asserted-by":"publisher","first-page":"215430","DOI":"10.1016\/j.ccr.2023.215430","volume":"497","author":"J Guo","year":"2023","unstructured":"Guo J, Xiong H, Liu H, Zhang T, Sun X. Radioiodine based biomedical carriers for cancer theranostics. Coord Chem Rev. 2023;497:215430.","journal-title":"Coord Chem Rev"},{"issue":"5","key":"3020_CR3","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1039\/D0MH01761B","volume":"8","author":"P Pei","year":"2021","unstructured":"Pei P, Liu T, Shen W, Liu Z, Yang K. Biomaterial-mediated internal radioisotope therapy. Mater Horiz. 2021;8(5):1348\u201366.","journal-title":"Mater Horiz"},{"issue":"1","key":"3020_CR4","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3797\/scipharm.1305-18","volume":"82","author":"A Aghanejad","year":"2014","unstructured":"Aghanejad A, Jalilian AR, Fazaeli Y, Alirezapoor B, Pouladi M, Beiki D, Maus S, Khalaj A. Synthesis and evaluation of [(67)Ga]-AMD3100: a novel imaging agent for targeting the chemokine receptor CXCR4. Sci Pharm. 2014;82(1):29\u201342.","journal-title":"Sci Pharm"},{"issue":"3","key":"3020_CR5","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1007\/s13139-015-0323-7","volume":"49","author":"A Mirzaei","year":"2015","unstructured":"Mirzaei A, Jalilian AR, Aghanejad A, Mazidi M, Yousefnia H, Shabani G, Ardaneh K, Geramifar P, Beiki D. Preparation and evaluation of (68)Ga-ECC as a PET renal imaging agent. Nucl Med Mol Imaging. 2015;49(3):208\u201316.","journal-title":"Nucl Med Mol Imaging"},{"issue":"3","key":"3020_CR6","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1007\/s10967-013-2822-2","volume":"299","author":"A Aghanejad","year":"2013","unstructured":"Aghanejad A, Jalilian AR, Fazaeli Y, Beiki D, Fateh B, Khalaj A. Radiosynthesis and biodistribution studies of [62Zn\/62Cu]\u2013plerixafor complex as a novel in vivo PET generator for chemokine receptor imaging. J Radioanal Nucl Chem. 2013;299(3):1635\u201344.","journal-title":"J Radioanal Nucl Chem"},{"issue":"4","key":"3020_CR7","doi-asserted-by":"publisher","first-page":"5036","DOI":"10.1021\/acsnano.1c10550","volume":"16","author":"I Roy","year":"2022","unstructured":"Roy I, Krishnan S, Kabashin AV, Zavestovskaya IN, Prasad PN. Transforming nuclear medicine with nanoradiopharmaceuticals. ACS Nano. 2022;16(4):5036\u201361.","journal-title":"ACS Nano"},{"issue":"5","key":"3020_CR8","doi-asserted-by":"publisher","first-page":"3355","DOI":"10.1039\/D0CS00384K","volume":"50","author":"J Pellico","year":"2021","unstructured":"Pellico J, Gawne PJ, de Rosales RTM. Radiolabelling of nanomaterials for medical imaging and therapy. Chem Soc Rev. 2021;50(5):3355\u2013423.","journal-title":"Chem Soc Rev"},{"key":"3020_CR9","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ijbiomac.2021.01.170","volume":"174","author":"PN Nabi","year":"2021","unstructured":"Nabi PN, Vahidfar N, Tohidkia MR, Hamidi AA, Omidi Y, Aghanejad A. Mucin-1 conjugated polyamidoamine-based nanoparticles for image-guided delivery of gefitinib to breast cancer. Int J Biol Macromol. 2021;174:185\u201397.","journal-title":"Int J Biol Macromol"},{"issue":"9","key":"3020_CR10","doi-asserted-by":"publisher","first-page":"3644","DOI":"10.1021\/acsbiomaterials.2c00287","volume":"8","author":"D Viswanath","year":"2022","unstructured":"Viswanath D, Won Y-Y. Combining radiotherapy (RT) and photodynamic therapy (PDT): clinical studies on conventional RT-PDT approaches and novel nanoparticle-based RT-PDT approaches under preclinical evaluation. ACS Biomater Sci Eng. 2022;8(9):3644\u201358.","journal-title":"ACS Biomater Sci Eng"},{"issue":"6","key":"3020_CR11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.22159\/ijap.2022v14i6.45064","volume":"14","author":"K Ramadoss","year":"2022","unstructured":"Ramadoss K, Vadivel V, Abishek V, Lakshmi K. Magnetic nanoparticle-based approaches in cancer therapy\u2013a critical review. Int J Appl Pharm. 2022;14(6):21\u201327. https:\/\/doi.org\/10.22159\/ijap.2022v14i6.45064.","journal-title":"Int J Appl Pharm"},{"key":"3020_CR12","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.biomaterials.2018.06.021","volume":"179","author":"EJL Steen","year":"2018","unstructured":"Steen EJL, Edem PE, Norregaard K, Jorgensen JT, Shalgunov V, Kjaer A, Herth MM. Pretargeting in nuclear imaging and radionuclide therapy: Improving efficacy of theranostics and nanomedicines. Biomaterials. 2018;179:209\u201345.","journal-title":"Biomaterials"},{"issue":"32","key":"3020_CR13","doi-asserted-by":"publisher","first-page":"1700996","DOI":"10.1002\/adma.201700996","volume":"29","author":"G Song","year":"2017","unstructured":"Song G, Cheng L, Chao Y, Yang K, Liu Z. Emerging nanotechnology and advanced materials for cancer radiation therapy. Adv Mater. 2017;29(32):1700996.","journal-title":"Adv Mater"},{"key":"3020_CR14","doi-asserted-by":"publisher","first-page":"102042","DOI":"10.1016\/j.nantod.2023.102042","volume":"53","author":"H Luo","year":"2023","unstructured":"Luo H, Ma W, Chen Q, Yang Z, Dai Y. Radiotherapy-activated tumor immune microenvironment: realizing radiotherapy-immunity combination therapy strategies. Nano Today. 2023;53:102042.","journal-title":"Nano Today"},{"issue":"8","key":"3020_CR15","doi-asserted-by":"publisher","first-page":"10001","DOI":"10.1021\/acsnano.0c03094","volume":"14","author":"W Fu","year":"2020","unstructured":"Fu W, Zhang X, Mei L, Zhou R, Yin W, Wang Q, Gu Z, Zhao Y. Stimuli-responsive small-on-large nanoradiosensitizer for enhanced tumor penetration and radiotherapy sensitization. ACS Nano. 2020;14(8):10001\u201317.","journal-title":"ACS Nano"},{"issue":"1","key":"3020_CR16","first-page":"130","volume":"1856","author":"JW Bergs","year":"2015","unstructured":"Bergs JW, Wacker MG, Hehlgans S, Piiper A, Multhoff G, R\u00f6del C, R\u00f6del F. The role of recent nanotechnology in enhancing the efficacy of radiation therapy. Biochim Biophys Acta. 2015;1856(1):130\u201343.","journal-title":"Biochim Biophys Acta"},{"issue":"12","key":"3020_CR17","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/s41578-023-00581-x","volume":"8","author":"PJ Gawne","year":"2023","unstructured":"Gawne PJ, Ferreira M, Papaluca M, Grimm J, Decuzzi P. New opportunities and old challenges in the clinical translation of nanotheranostics. Nat Rev Mater. 2023;8(12):783\u201398.","journal-title":"Nat Rev Mater"},{"issue":"15","key":"3020_CR18","doi-asserted-by":"publisher","first-page":"4190","DOI":"10.1158\/1078-0432.CCR-16-3193","volume":"23","author":"H Lee","year":"2017","unstructured":"Lee H, Shields AF, Siegel BA, Miller KD, Krop I, Ma CX, LoRusso PM, Munster PN, Campbell K, Gaddy DF, Leonard SC, Geretti E, Blocker SJ, Kirpotin DB, Moyo V, Wickham TJ, Hendriks BS. (64)Cu-MM-302 positron emission tomography quantifies variability of enhanced permeability and retention of nanoparticles in relation to treatment response in patients with metastatic breast cancer. Clin Cancer Res. 2017;23(15):4190\u2013202.","journal-title":"Clin Cancer Res"},{"issue":"21","key":"3020_CR19","doi-asserted-by":"publisher","first-page":"e2201043","DOI":"10.1002\/adma.202201043","volume":"34","author":"IHC Miedema","year":"2022","unstructured":"Miedema IHC, Zwezerijnen GJC, Huisman MC, Doeleman E, Mathijssen RHJ, Lammers T, Hu Q, van Dongen G, Rijcken CJF, Vugts DJ, van Oordt CWMH. PET-CT imaging of polymeric nanoparticle tumor accumulation in patients. Adv Mater. 2022;34(21):e2201043.","journal-title":"Adv Mater"},{"key":"3020_CR20","doi-asserted-by":"publisher","unstructured":"Wang SJ. A phase 0 study of the pharmacokinetics, biodistribution, and dosimetry of (188)Re-liposome in patients with metastatic tumors. EJNMMI Res. 2019;9(46). https:\/\/doi.org\/10.1186\/s13550-019-0509-6.","DOI":"10.1186\/s13550-019-0509-6"},{"key":"3020_CR21","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1038\/s41565-024-01754-7","volume":"19","author":"P Joyce","year":"2024","unstructured":"Joyce P, Allen CJ, Alonso MJ, Ashford M, Bradbury MS, Germain M, Kavallaris M, Langer R, Lammers T, Peracchia MT, Popat A, Prestidge CA, Rijcken CJF, Sarmento B, Schmid RB, Schroeder A, Subramaniam S, Thorn CR, Whitehead KA, Zhao CX, Santos HA. A translational framework to DELIVER nanomedicines to the clinic. Nat Nanotechnol. 2024;19:1748\u20133395.","journal-title":"Nat Nanotechnol"},{"issue":"6","key":"3020_CR22","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.3390\/pharmaceutics15061733","volume":"15","author":"N Lepareur","year":"2023","unstructured":"Lepareur N, Ramee B, Mougin-Degraef M, Bourgeois M. Clinical advances and perspectives in targeted radionuclide therapy. Pharmaceutics. 2023;15(6):1733.","journal-title":"Pharmaceutics"},{"key":"3020_CR23","doi-asserted-by":"publisher","first-page":"S89","DOI":"10.1016\/j.ijrobp.2006.03.066","volume":"66","author":"SJ de Nardo","year":"2006","unstructured":"de Nardo SJ, de Nardo GL. Targeted radionuclide therapy for solid tumors: an overview. Int J Radiat Oncol Biol Phys. 2006;66:S89\u201395.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3020_CR24","doi-asserted-by":"publisher","first-page":"214702","DOI":"10.1016\/j.ccr.2022.214702","volume":"470","author":"L Wagner","year":"2022","unstructured":"Wagner L, Kenzhebayeva B, Dhaini B, Boukhlef S, Moussaron A, Mordon S, Frochot C, Collet C, Acherar S. Folate-based radiotracers for nuclear imaging and radionuclide therapy. Coord Chem Rev. 2022;470:214702.","journal-title":"Coord Chem Rev"},{"key":"3020_CR25","doi-asserted-by":"publisher","first-page":"117452","DOI":"10.1016\/j.trac.2023.117452","volume":"170","author":"P Xu","year":"2024","unstructured":"Xu P, Lin S, Wang Y, Abdukayum A, Wang Y. Radionuclide-based Cerenkov luminescence in biomedicine: current research progress and future perspectives. TrAC, Trends Anal Chem. 2024;170:117452.","journal-title":"TrAC, Trends Anal Chem"},{"key":"3020_CR26","doi-asserted-by":"publisher","first-page":"102174","DOI":"10.1016\/j.nantod.2024.102174","volume":"55","author":"M Teng","year":"2024","unstructured":"Teng M, Liang X, Liu H, Li Z, Gao X, Zhang C, Cheng H, Chen H, Liu G. Cerenkov radiation shining a light for cancer theranostics. Nano Today. 2024;55:102174.","journal-title":"Nano Today"},{"issue":"2","key":"3020_CR27","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nnano.2016.301","volume":"12","author":"TM Shaffer","year":"2017","unstructured":"Shaffer TM, Pratt EC, Grimm J. Utilizing the power of Cerenkov light with nanotechnology. Nat Nanotechnol. 2017;12(2):106\u201317.","journal-title":"Nat Nanotechnol"},{"issue":"17","key":"3020_CR28","doi-asserted-by":"publisher","first-page":"7404","DOI":"10.7150\/thno.75279","volume":"12","author":"N Liu","year":"2022","unstructured":"Liu N, Su X, Sun X. Cerenkov radiation-activated probes for deep cancer theranostics: a review. Theranostics. 2022;12(17):7404\u201319.","journal-title":"Theranostics"},{"issue":"4","key":"3020_CR29","doi-asserted-by":"publisher","first-page":"04TR01","DOI":"10.1088\/1361-6560\/aaf4de","volume":"64","author":"JS Klein","year":"2019","unstructured":"Klein JS, Sun C, Pratx G. Radioluminescence in biomedicine: physics, applications, and models. Phys Med Biol. 2019;64(4):04TR01.","journal-title":"Phys Med Biol"},{"key":"3020_CR30","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.nucmedbio.2021.05.001","volume":"98\u201399","author":"SK Suman","year":"2021","unstructured":"Suman SK, Subramanian S, Mukherjee A. Combination radionuclide therapy: a new paradigm. Nucl Med Biol. 2021;98\u201399:40\u201358.","journal-title":"Nucl Med Biol"},{"issue":"5","key":"3020_CR31","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.3390\/pharmaceutics15051378","volume":"15","author":"CN Funeh","year":"2023","unstructured":"Funeh CN, Bridoux J, Ertveldt T, De Groof TWM, Chigoho DM, Asiabi P, Covens P, D\u2019Huyvetter M, Devoogdt N. Optimizing the safety and efficacy of bio-radiopharmaceuticals for cancer therapy. Pharmaceutics. 2023;15(5):1378.","journal-title":"Pharmaceutics"},{"issue":"1","key":"3020_CR32","doi-asserted-by":"publisher","first-page":"664","DOI":"10.3390\/ijms25010664","volume":"25","author":"G Trencs\u00e9nyi","year":"2024","unstructured":"Trencs\u00e9nyi G, Csikos C, K\u00e9pes Z. Targeted radium alpha therapy in the era of nanomedicine: in vivo results. Int J Mol Sci. 2024;25(1):664.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"3020_CR33","doi-asserted-by":"publisher","first-page":"e281","DOI":"10.1016\/j.clgc.2018.11.014","volume":"17","author":"EW Bouman-Wammes","year":"2019","unstructured":"Bouman-Wammes EW, de Klerk JMH, Bloemendal HJ, de van Jong JMD, Lange R, ter Heine R, Verheul HMW, Eertwegh AJM. Bone-targeting radiopharmaceuticals as monotherapy or combined with chemotherapy in patients with castration-resistant prostate cancer metastatic to bone. Clin Genitourin Cancer. 2019;17(2):e281\u201392.","journal-title":"Clin Genitourin Cancer"},{"issue":"23","key":"3020_CR34","doi-asserted-by":"publisher","first-page":"6824","DOI":"10.7150\/thno.36739","volume":"9","author":"YHW Derks","year":"2019","unstructured":"Derks YHW, L\u00f6wik DWPM, Sedelaar JPM, Gotthardt M, Boerman OC, Rijpkema M, L\u00fctje S, Heskamp S. PSMA-targeting agents for radio- and fluorescence-guided prostate cancer surgery. Theranostics. 2019;9(23):6824\u201339.","journal-title":"Theranostics"},{"issue":"12","key":"3020_CR35","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1016\/j.addr.2008.04.009","volume":"60","author":"M Miederer","year":"2008","unstructured":"Miederer M, Scheinberg DA, McDevitt MR. Realizing the potential of the Actinium-225 radionuclide generator in targeted alpha particle therapy applications. Adv Drug Deliv Rev. 2008;60(12):1371\u201382.","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"3020_CR36","doi-asserted-by":"publisher","first-page":"228","DOI":"10.2967\/jnumed.120.246041","volume":"62","author":"J Czernin","year":"2021","unstructured":"Czernin J, Current K, Mona CE, Nyiranshuti L, Hikmat F, Radu CG, L\u00fcckerath K. Immune-checkpoint blockade enhances 225Ac-PSMA617 efficacy in a mouse model of prostate cancer. J Nucl Med. 2021;62(2):228\u201331.","journal-title":"J Nucl Med"},{"key":"3020_CR37","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.nucmedbio.2021.03.009","volume":"96\u201397","author":"M Staniszewska","year":"2021","unstructured":"Staniszewska M, Iking J, L\u00fcckerath K, Hadaschik B, Herrmann K, Ferdinandus J, Fendler WP. Drug and molecular radiotherapy combinations for metastatic castration resistant prostate cancer. Nucl Med Biol. 2021;96\u201397:101\u201311.","journal-title":"Nucl Med Biol"},{"issue":"3","key":"3020_CR38","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/s00259-016-3527-x","volume":"44","author":"G Kong","year":"2016","unstructured":"Kong G, Callahan J, Hofman MS, Pattison DA, Akhurst T, Michael M, Eu P, Hicks RJ. High clinical and morphologic response using 90Y-DOTA-octreotate sequenced with 177Lu-DOTA-octreotate induction peptide receptor chemoradionuclide therapy (PRCRT) for bulky neuroendocrine tumours. Eur J Nucl Med Mol Imaging. 2016;44(3):476\u201389.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"10","key":"3020_CR39","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.3390\/ph14101005","volume":"14","author":"A Yordanova","year":"2021","unstructured":"Yordanova A, Ahmadzadehfar H. Combination therapies with PRRT. Pharmaceuticals. 2021;14(10):1005.","journal-title":"Pharmaceuticals"},{"issue":"6","key":"3020_CR40","doi-asserted-by":"publisher","first-page":"878","DOI":"10.2967\/jnumed.116.186338","volume":"59","author":"S Poty","year":"2018","unstructured":"Poty S, Francesconi LC, McDevitt MR, Morris MJ, Lewis JS. \u03b1-Emitters for radiotherapy: from basic radiochemistry to clinical studies-part 1. J Nucl Med. 2018;59(6):878\u201384.","journal-title":"J Nucl Med"},{"issue":"4","key":"3020_CR41","doi-asserted-by":"publisher","first-page":"76","DOI":"10.3390\/ph13040076","volume":"13","author":"M Roscher","year":"2020","unstructured":"Roscher M, Bakos G, Bene\u0161ov\u00e1 M. Atomic nanogenerators in targeted alpha therapies: Curie\u2019s legacy in modern cancer management. Pharmaceuticals. 2020;13(4):76.","journal-title":"Pharmaceuticals"},{"key":"3020_CR42","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.addr.2015.12.003","volume":"109","author":"S Aghevlian","year":"2017","unstructured":"Aghevlian S, Boyle AJ, Reilly RM. Radioimmunotherapy of cancer with high linear energy transfer (LET) radiation delivered by radionuclides emitting \u03b1-particles or Auger electrons. Adv Drug Deliv Rev. 2017;109:102\u201318.","journal-title":"Adv Drug Deliv Rev"},{"key":"3020_CR43","doi-asserted-by":"publisher","first-page":"215733","DOI":"10.1016\/j.ccr.2024.215733","volume":"507","author":"L Lv","year":"2024","unstructured":"Lv L, Fan B, Ji X, Liu Y, Chen T, Li Y, Gao X, Chen P, Tang B, Chen G. From the clinical perspective of photodynamic therapy and photothermal Therapy: structure-activity-practice. Coord Chem Rev. 2024;507:215733.","journal-title":"Coord Chem Rev"},{"issue":"8109","key":"3020_CR44","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/S0140-6736(79)90594-4","volume":"313","author":"JA Dickson","year":"1979","unstructured":"Dickson JA. Hyperthermia in the treatment of cancer. Lancet. 1979;313(8109):202\u20135.","journal-title":"Lancet"},{"issue":"3","key":"3020_CR45","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s10103-007-0470-x","volume":"23","author":"X Huang","year":"2008","unstructured":"Huang X, Jain PK, El-Sayed IH, El-Sayed MA. Plasmonic photothermal therapy (PPTT) using gold nanoparticles. Lasers Med Sci. 2008;23(3):217\u201328.","journal-title":"Lasers Med Sci"},{"key":"3020_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.125826","volume":"247","author":"M Li","year":"2023","unstructured":"Li M, Xuan Y, Zhang W, Zhang S, An J. Polydopamine-containing nano-systems for cancer multi-mode diagnoses and therapies: a review. Int J Biol Macromol. 2023;247: 125826.","journal-title":"Int J Biol Macromol"},{"issue":"11","key":"3020_CR47","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.7150\/thno.16047","volume":"6","author":"H Zhao","year":"2016","unstructured":"Zhao H, Chao Y, Liu J, Huang J, Pan J, Guo W, Wu J, Sheng M, Yang K, Wang J, Liu Z. Polydopamine coated single-walled carbon nanotubes as a versatile platform with radionuclide labeling for multimodal tumor imaging and therapy. Theranostics. 2016;6(11):1833\u201343.","journal-title":"Theranostics"},{"issue":"35","key":"3020_CR48","doi-asserted-by":"publisher","first-page":"15021","DOI":"10.1039\/D1NR02892H","volume":"13","author":"S Huang","year":"2021","unstructured":"Huang S, Wu Y, Li C, Xu L, Huang J, Huang Y, Cheng W, Xue B, Zhang L, Liang S, Jin X, Zhu X, Xiong S, Su Y, Wang H. Tailoring morphologies of mesoporous polydopamine nanoparticles to deliver high-loading radioiodine for anaplastic thyroid carcinoma imaging and therapy. Nanoscale. 2021;13(35):15021\u201330.","journal-title":"Nanoscale"},{"issue":"45","key":"3020_CR49","doi-asserted-by":"publisher","first-page":"9316","DOI":"10.1039\/D1TB02115J","volume":"9","author":"D Cheng","year":"2021","unstructured":"Cheng D, Gong J, Wang P, Zhu J, Yu N, Zhao J, Zhang Q, Li J. 131I-Labeled gold nanoframeworks for radiotherapy-combined second near-infrared photothermal therapy of cancer. J Mater Chem B. 2021;9(45):9316\u201323.","journal-title":"J Mater Chem B"},{"key":"3020_CR50","doi-asserted-by":"publisher","first-page":"889284","DOI":"10.3389\/fonc.2022.889284","volume":"12","author":"X Zhang","year":"2022","unstructured":"Zhang X, Yan Z, Meng Z, Li N, Jia Q, Shen Y, Ji Y. Radionuclide 131I-labeled albumin-indocyanine green nanoparticles for synergistic combined radio-photothermal therapy of anaplastic thyroid cancer. Front Oncol. 2022;12:889284.","journal-title":"Front Oncol"},{"issue":"21","key":"3020_CR51","doi-asserted-by":"publisher","first-page":"e2100378","DOI":"10.1002\/smll.202100378","volume":"17","author":"L Xia","year":"2021","unstructured":"Xia L, Meng X, Wen L, Zhou N, Liu T, Xu X, Wang F, Cheng Z, Yang Z, Zhu H. A highly specific multiple enhancement theranostic nanoprobe for PET\/MRI\/PAI image-guided radioisotope combined photothermal therapy in prostate cancer. Small. 2021;17(21):e2100378.","journal-title":"Small"},{"key":"3020_CR52","doi-asserted-by":"publisher","unstructured":"Lee SB, Lee JE, Cho SJ. Crushed gold shell nanoparticles labeled with radioactive iodine as a theranostic nanoplatform for macrophage-mediated photothermal therapy. Nano-Micro Lett. 2019;11(36). https:\/\/doi.org\/10.1007\/s40820-019-0266-0.","DOI":"10.1007\/s40820-019-0266-0"},{"issue":"10","key":"3020_CR53","doi-asserted-by":"publisher","first-page":"13460","DOI":"10.1021\/acsami.2c20619","volume":"15","author":"OO Peltek","year":"2023","unstructured":"Peltek OO, Karpov TE, Rogova A, Postovalova A, Ageev E, Petrov A, Antuganov D, Stanzhevsky AA, Maistrenko DN, Zuev D, Muslimov AR, Timin AS, Zyuzin MV. Development of nanocarrier-based radionuclide and photothermal therapy in combination with chemotherapy in melanoma cancer treatment. ACS Appl Mater Interfaces. 2023;15(10):13460\u201371.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"6","key":"3020_CR54","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.3390\/pharmaceutics14061284","volume":"14","author":"M Sim\u00f3n","year":"2022","unstructured":"Sim\u00f3n M, J\u00f8rgensen JT, Khare HA, Christensen C, Nielsen CH, Kjaer A. Combination of [177Lu]Lu-DOTA-TATE targeted radionuclide therapy and photothermal therapy as a promising approach for cancer treatment: in vivo studies in a human xenograft mouse model. Pharmaceutics. 2022;14(6):1284.","journal-title":"Pharmaceutics"},{"issue":"36","key":"3020_CR55","doi-asserted-by":"publisher","first-page":"eado9664","DOI":"10.1126\/sciadv.ado9664","volume":"10","author":"M Wang","year":"2024","unstructured":"Wang M, Jia J, Meng Z, Xia J, Hu X, Xue F, Peng H, Meng X, Yi J, Chen X, Li J, Guo Y, Xu Y, Huang X. Plasmonic Pd-Sb nanosheets for photothermal CH4 conversion to HCHO and therapy. Sci Adv. 2024;10(36):eado9664.","journal-title":"Sci Adv"},{"issue":"18","key":"3020_CR56","doi-asserted-by":"publisher","first-page":"4268","DOI":"10.1039\/C8SC00104A","volume":"9","author":"M Chen","year":"2018","unstructured":"Chen M, Guo Z, Chen Q, Wei J, Li J, Shi C, Xu D, Zhou D, Zhang X, Zheng N. Pd nanosheets with their surface coordinated by radioactive iodide as a high-performance theranostic nanoagent for orthotopic hepatocellular carcinoma imaging and cancer therapy. Chem Sci. 2018;9(18):4268\u201374.","journal-title":"Chem Sci"},{"key":"3020_CR57","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.biomaterials.2018.06.040","volume":"179","author":"Z Guo","year":"2018","unstructured":"Guo Z, Chen M, Peng C, Mo S, Shi C, Fu G, Wen X, Zhuang R, Su X, Liu T, Zheng N, Zhang X. pH-sensitive radiolabeled and superfluorinated ultra-small palladium nanosheet as a high-performance multimodal platform for tumor theranostics. Biomaterials. 2018;179:134\u201343.","journal-title":"Biomaterials"},{"issue":"2","key":"3020_CR58","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s00262-002-0335-x","volume":"52","author":"A Ito","year":"2003","unstructured":"Ito A, Shinkai M, Honda H, Yoshikawa K, Saga S, Wakabayashi T, Yoshida J, Kobayashi T. Heat shock protein 70 expression induces antitumor immunity during intracellular hyperthermia using magnetite nanoparticles. Cancer Immunol Immunother. 2003;52(2):80\u20138.","journal-title":"Cancer Immunol Immunother"},{"key":"3020_CR59","doi-asserted-by":"publisher","first-page":"119628","DOI":"10.1016\/j.ijpharm.2020.119628","volume":"587","author":"A Stankovi\u0107","year":"2020","unstructured":"Stankovi\u0107 A, Mihailovi\u0107 J, Mirkovi\u0107 M, Radovi\u0107 M, Milanovi\u0107 Z, Ognjanovi\u0107 M, Jankovi\u0107 D, Anti\u0107 B, Mijovi\u0107 M, Vranje\u0161-\u0110uri\u0107 S, Prijovi\u0107 \u017d. Aminosilanized flower-structured superparamagnetic iron oxide nanoparticles coupled to 131I-labeled CC49 antibody for combined radionuclide and hyperthermia therapy of cancer. Int J Pharm. 2020;587:119628.","journal-title":"Int J Pharm"},{"issue":"6","key":"3020_CR60","doi-asserted-by":"publisher","first-page":"5282","DOI":"10.3390\/ijms24065282","volume":"24","author":"NA Gharibkandi","year":"2023","unstructured":"Gharibkandi NA, \u017buk M, Muftuler FZB, Wawrowicz K, \u017belechowska-Matysiak K, Bilewicz A. 198Au-coated superparamagnetic iron oxide nanoparticles for dual magnetic hyperthermia and radionuclide therapy of hepatocellular carcinoma. Int J Mol Sci. 2023;24(6):5282.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"3020_CR61","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.3390\/molecules25051025","volume":"25","author":"E C\u0119drowska","year":"2020","unstructured":"C\u0119drowska E, Pruszy\u0144ski M, Gaw\u0119da W, \u017buk M, Krysi\u0144ski P, Bruchertseifer F, Morgenstern A, Karageorgou M-A, Bouziotis P, Bilewicz A. Trastuzumab conjugated superparamagnetic iron oxide nanoparticles labeled with 225Ac as a perspective tool for combined \u03b1-radioimmunotherapy and magnetic hyperthermia of HER2-positive breast cancer. Molecules. 2020;25(5):1025.","journal-title":"Molecules"},{"issue":"1","key":"3020_CR62","doi-asserted-by":"publisher","first-page":"33524","DOI":"10.1038\/srep33524","volume":"6","author":"M Lin","year":"2016","unstructured":"Lin M, Huang J, Jiang X, Zhang J, Yu H, Ye J, Zhang D. A combination hepatoma-targeted therapy based on nanotechnology: pHRE-Egr1-HSV-TK\/131I-antiAFPMcAb-GCV\/MFH. Sci Rep. 2016;6(1):33524.","journal-title":"Sci Rep"},{"key":"3020_CR63","doi-asserted-by":"publisher","first-page":"247","DOI":"10.2147\/IJN.S337599","volume":"17","author":"N Sun","year":"2022","unstructured":"Sun N, Wen X, Zhang S. Strategies to improve photodynamic therapy efficacy of metal-free semiconducting conjugated polymers. Int J Nanomed. 2022;17:247\u201371.","journal-title":"Int J Nanomed"},{"key":"3020_CR64","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/978-3-642-74626-0_2","volume-title":"Selected papers","author":"I Frank","year":"1991","unstructured":"Frank I, Tamm I. Coherent visible radiation of fast electrons passing through matter. In: Tamm IE, Bolotovskii BM, Frenkel VY, Peierls R, editors. Selected papers. Berlin: Springer; 1991. p. 29\u201335."},{"issue":"1","key":"3020_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1011-1344(96)07428-3","volume":"39","author":"M Ochsner","year":"1997","unstructured":"Ochsner M. Photophysical and photobiological processes in the photodynamic therapy of tumours. J Photochem Photobiol, B. 1997;39(1):1\u201318.","journal-title":"J Photochem Photobiol, B"},{"issue":"12","key":"3020_CR66","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1093\/jnci\/90.12.889","volume":"90","author":"TJ Dougherty","year":"1998","unstructured":"Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, Korbelik M, Moan J, Peng Q. Photodynamic therapy. J Natl Cancer Inst. 1998;90(12):889\u2013905.","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"3020_CR67","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.nucmedbio.2007.05.006","volume":"34","author":"Z Jia","year":"2007","unstructured":"Jia Z, Deng H, Pu M. Synthesis and preliminary biological studies of the novel conjugate 188Re-labeled meso-tetrakis(4-sulfophenyl)porphyrin in mice. Nucl Med Biol. 2007;34(6):643\u20139.","journal-title":"Nucl Med Biol"},{"issue":"4","key":"3020_CR68","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1007\/s00259-007-0682-0","volume":"35","author":"Z-Y Jia","year":"2008","unstructured":"Jia Z-Y, Deng H-F, Pu M-F, Luo S-Z. Rhenium-188 labelled meso-tetrakis[3,4-bis(carboxymethyleneoxy)phenyl] porphyrin for targeted radiotherapy: preliminary biological evaluation in mice. Eur J Nucl Med Mol Imaging. 2008;35(4):734\u201342.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"3020_CR69","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.nucmedbio.2010.02.007","volume":"37","author":"T Das","year":"2010","unstructured":"Das T, Chakraborty S, Sarma HD, Banerjee S, Venakatesh M. A novel 177Lu-labeled porphyrin for possible use in targeted tumor therapy. Nucl Med Biol. 2010;37(5):655\u201363.","journal-title":"Nucl Med Biol"},{"issue":"7","key":"3020_CR70","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s12149-013-0728-2","volume":"27","author":"H Mukai","year":"2013","unstructured":"Mukai H, Wada Y, Watanabe Y. The synthesis of 64Cu-chelated porphyrin photosensitizers and their tumor-targeting peptide conjugates for the evaluation of target cell uptake and PET image-based pharmacokinetics of targeted photodynamic therapy agents. Ann Nucl Med. 2013;27(7):625\u201339.","journal-title":"Ann Nucl Med"},{"issue":"1","key":"3020_CR71","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s10967-014-3113-2","volume":"301","author":"N Vahidfar","year":"2014","unstructured":"Vahidfar N, Jalilian AR, Fazaeli Y, Bahrami-Samani A, Beiki D, Khalaj A. Radiosynthesis and biological evaluation of 166Ho labeled methoxylated porphyrins as possible therapeutic agents. J Radioanal Nucl Chem. 2014;301(1):269\u201376.","journal-title":"J Radioanal Nucl Chem"},{"issue":"1","key":"3020_CR72","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s10967-018-5735-2","volume":"316","author":"H Song","year":"2018","unstructured":"Song H, Wang G, Wang J, Wang Y, Wei H, He J, Luo S. 131I-labeled 5,10,15,20-tetrakis(4-hydroxyphenyl)porphyrin and 5,10,15,20-tetrakis(4-aminophenyl)porphyrin for combined photodynamic and radionuclide therapy. J Radioanal Nucl Chem. 2018;316(1):363\u20138.","journal-title":"J Radioanal Nucl Chem"},{"issue":"2","key":"3020_CR73","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1615\/JEnvironPatholToxicolOncol.2016016903","volume":"35","author":"BA Hartl","year":"2016","unstructured":"Hartl BA, Hirschberg H, Marcu L, Cherry SR. Activating photodynamic therapy in vitro with cerenkov radiation generated from Yttrium-90. J Environ Pathol Toxicol Oncol. 2016;35(2):185\u201392.","journal-title":"J Environ Pathol Toxicol Oncol"},{"issue":"52","key":"3020_CR74","doi-asserted-by":"publisher","first-page":"e1904894","DOI":"10.1002\/adma.201904894","volume":"31","author":"B Yu","year":"2019","unstructured":"Yu B, Ni D, Rosenkrans ZT, Barnhart TE, Wei H, Ferreira CA, Lan X, Engle JW, He Q, Yu F, Cai W. A \u201cmissile-detonation\u201d strategy to precisely supply and efficiently amplify cerenkov radiation energy for cancer theranostics. Adv Mater. 2019;31(52):e1904894.","journal-title":"Adv Mater"},{"issue":"1","key":"3020_CR75","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1002\/anie.201710232","volume":"57","author":"B Yu","year":"2018","unstructured":"Yu B, Wei H, He Q, Ferreira CA, Kutyreff CJ, Ni D, Rosenkrans ZT, Cheng L, Yu F, Engle JW, Lan X, Cai W. Efficient uptake of (177) Lu-Porphyrin-PEG Nanocomplexes by tumor mitochondria for multimodal-imaging-guided combination therapy. Angew Chem Int Ed Engl. 2018;57(1):218\u201322.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"44","key":"3020_CR76","doi-asserted-by":"publisher","first-page":"14971","DOI":"10.1021\/jacs.8b09374","volume":"140","author":"D Ni","year":"2018","unstructured":"Ni D, Ferreira CA, Barnhart TE, Quach V, Yu B, Jiang D, Wei W, Liu H, Engle JW, Hu P, Cai W. Magnetic targeting of nanotheranostics enhances cerenkov radiation-induced photodynamic therapy. J Am Chem Soc. 2018;140(44):14971\u20139.","journal-title":"J Am Chem Soc"},{"issue":"6","key":"3020_CR77","doi-asserted-by":"publisher","first-page":"1704367","DOI":"10.1002\/adma.201704367","volume":"30","author":"S Goel","year":"2018","unstructured":"Goel S, Ferreira CA, Chen F, Ellison PA, Siamof CM, Barnhart TE, Cai W. Activatable hybrid nanotheranostics for tetramodal imaging and synergistic photothermal\/photodynamic therapy. Adv Mater. 2018;30(6):1704367.","journal-title":"Adv Mater"},{"key":"3020_CR78","doi-asserted-by":"publisher","first-page":"114641","DOI":"10.1016\/j.jphotochem.2023.114641","volume":"439","author":"KLS Zhu","year":"2023","unstructured":"Zhu KLS, Qin S, Lin J, Qiu L. Cerenkov radiation induced chemo-photodynamic therapy using ROS-responsive agent. J Photochem Photobiol. 2023;439:114641.","journal-title":"J Photochem Photobiol"},{"issue":"4","key":"3020_CR79","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/nnano.2015.17","volume":"10","author":"N Kotagiri","year":"2015","unstructured":"Kotagiri N, Sudlow GP, Akers WJ, Achilefu S. Breaking the depth dependency of phototherapy with Cerenkov radiation and low-radiance-responsive nanophotosensitizers. Nat Nanotechnol. 2015;10(4):370\u20139.","journal-title":"Nat Nanotechnol"},{"key":"3020_CR80","doi-asserted-by":"publisher","first-page":"826","DOI":"10.2174\/1573411018666220321102736","volume":"18","author":"HHL Fang","year":"2022","unstructured":"Fang HHL, Quirk JD, Zheng J, Shen D, Manion B, Mixdorf M, Karmakar P, Sudlow GP, Tang R, Achilefu S. Analysis of stable chelate-free gadolinium loaded titanium dioxide nanoparticles for MRI-guided radionuclide stimulated cancer treatment. Curr Anal Chem. 2022;18:826\u201335.","journal-title":"Curr Anal Chem"},{"issue":"6","key":"3020_CR81","doi-asserted-by":"publisher","first-page":"5278","DOI":"10.1021\/acsami.7b17902","volume":"10","author":"D Duan","year":"2018","unstructured":"Duan D, Liu H, Xu Y, Han Y, Xu M, Zhang Z, Liu Z. Activating TiO2 nanoparticles: Gallium-68 serves as a high-yield photon emitter for Cerenkov-induced photodynamic therapy. ACS Appl Mater Interfaces. 2018;10(6):5278\u201386.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"4","key":"3020_CR82","doi-asserted-by":"publisher","first-page":"4255","DOI":"10.1021\/acsnano.9b09618","volume":"14","author":"R Tang","year":"2020","unstructured":"Tang R, Zheleznyak A, Mixdorf M, Ghai A, Prior J, Black KCL, Shokeen M, Reed N, Biswas P, Achilefu S. Osteotropic radiolabeled nanophotosensitizer for imaging and treating multiple myeloma. ACS Nano. 2020;14(4):4255\u201364.","journal-title":"ACS Nano"},{"key":"3020_CR83","doi-asserted-by":"publisher","first-page":"3689","DOI":"10.1021\/acsami.2c09195","volume":"15","author":"JY Lee","year":"2023","unstructured":"Lee JY, Choi PS, Chae JH. Theranostics through utilizing cherenkov radiation of radioisotope Zr-89 with a nanocomposite combination of TiO2 and MnO2. ACS Appl Mater Interfaces. 2023;15:3689\u201398.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"5","key":"3020_CR84","doi-asserted-by":"publisher","first-page":"702","DOI":"10.2967\/jnumed.118.215608","volume":"60","author":"S Kavadiya","year":"2019","unstructured":"Kavadiya S, Biswas P. Design of Cerenkov radiation-assisted photoactivation of TiO2 nanoparticles and reactive oxygen species generation for cancer treatment. J Nucl Med. 2019;60(5):702\u20139.","journal-title":"J Nucl Med"},{"issue":"1","key":"3020_CR85","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s12951-022-01401-0","volume":"20","author":"R Qian","year":"2022","unstructured":"Qian R, Wang K, Guo Y, Li H, Zhu Z, Huang X, Gong C, Gao Y, Guo R, Yang B, Wang C, Jiang D, Lan X, An R, Gao Z. Minimizing adverse effects of Cerenkov radiation induced photodynamic therapy with transformable photosensitizer-loaded nanovesicles. J Nanobiotechnol. 2022;20(1):203.","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"3020_CR86","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s41467-017-02758-9","volume":"9","author":"N Kotagiri","year":"2018","unstructured":"Kotagiri N, Cooper ML, Rettig M, Egbulefu C, Prior J, Cui G, Karmakar P, Zhou M, Yang X, Sudlow G, Marsala L, Chanswangphuwana C, Lu L, Habimana-Griffin L, Shokeen M, Xu X, Weilbaecher K, Tomasson M, Lanza G, DiPersio JF, Achilefu S. Radionuclides transform chemotherapeutics into phototherapeutics for precise treatment of disseminated cancer. Nat Commun. 2018;9(1):275.","journal-title":"Nat Commun"},{"key":"3020_CR87","doi-asserted-by":"publisher","first-page":"21884","DOI":"10.1002\/anie.202107231","volume":"60","author":"J Guo","year":"2021","unstructured":"Guo J, Feng K, Wu W, Ruan Y, Liu H, Han X, Shao G, Sun X. Smart 131I labeled self-illuminating photosensitizers for deep tumor imaging guided therapy. Angew Chem Int Ed. 2021;60:21884.","journal-title":"Angew Chem Int Ed"},{"issue":"3","key":"3020_CR88","doi-asserted-by":"publisher","first-page":"3875","DOI":"10.1021\/acsami.1c21860","volume":"14","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Wang G, Li Q, Jiang Y, Chen W, Zhao M, Liang G, Miao Q. Acidity-activated charge conversion of 177Lu-labeled nanoagent for the enhanced photodynamic radionuclide therapy of cancer. ACS Appl Mater Interfaces. 2022;14(3):3875\u201384.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"40","key":"3020_CR89","doi-asserted-by":"publisher","first-page":"26630","DOI":"10.1021\/acsami.6b10255","volume":"8","author":"A Kamkaew","year":"2016","unstructured":"Kamkaew A, Cheng L, Goel S, Valdovinos HF, Barnhart TE, Liu Z, Cai W. Cerenkov radiation induced photodynamic therapy using chlorin e6-loaded hollow mesoporous silica nanoparticles. ACS Appl Mater Interfaces. 2016;8(40):26630\u20137.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"46","key":"3020_CR90","doi-asserted-by":"publisher","first-page":"54727","DOI":"10.1021\/acsami.1c16213","volume":"13","author":"J Li","year":"2021","unstructured":"Li J, Dai S, Qin R, Shi C, Ming J, Zeng X, Wen X, Zhuang R, Chen X, Guo Z, Zhang X. Ligand engineering of titanium-oxo nanoclusters for Cerenkov radiation-reinforced photo\/chemodynamic tumor therapy. ACS Appl Mater Interfaces. 2021;13(46):54727\u201338.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"5","key":"3020_CR91","doi-asserted-by":"publisher","first-page":"2000802","DOI":"10.1002\/adhm.202000802","volume":"10","author":"Q Wang","year":"2020","unstructured":"Wang Q, Liu N, Hou Z, Shi J, Su X, Sun X. Radioiodinated persistent luminescence nanoplatform for radiation-induced photodynamic therapy and radiotherapy. Adv Healthcare Mater. 2020;10(5):2000802.","journal-title":"Adv Healthcare Mater"},{"key":"3020_CR92","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1007\/s00259-022-05685-0","volume":"49","author":"YHW Derks","year":"2022","unstructured":"Derks YHW, Lith SAM, Amatdjais-Groenen HIV, Wouters LWM, Kip A, Franssen GM, Laverman P, L\u00f6wik DWPM, Heskamp S, Rijpkema M. Theranostic PSMA ligands with optimized backbones for intraoperative multimodal imaging and photodynamic therapy of prostate cancer. Eur J Nucl Med Mol Imaging. 2022;49:2425\u201335.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3020_CR93","doi-asserted-by":"publisher","first-page":"7443","DOI":"10.2147\/IJN.S91008","volume":"10","author":"Y-H Shih","year":"2015","unstructured":"Shih Y-H, Peng C-L, Chiang P-F, Lin W-J, Luo T-Y, Shieh M-J. Therapeutic and scintigraphic applications of polymeric micelles: combination of chemotherapy and radiotherapy in hepatocellular carcinoma. Int J Nanomed. 2015;10:7443\u201354.","journal-title":"Int J Nanomed"},{"issue":"47","key":"3020_CR94","doi-asserted-by":"publisher","first-page":"7327","DOI":"10.1002\/adfm.201503587","volume":"25","author":"X Zhong","year":"2015","unstructured":"Zhong X, Yang K, Dong Z, Yi X, Wang Y, Ge C, Zhao Y, Liu Z. Polydopamine as a biocompatible multifunctional nanocarrier for combined radioisotope therapy and chemotherapy of cancer. Adv Func Mater. 2015;25(47):7327\u201336.","journal-title":"Adv Func Mater"},{"issue":"9","key":"3020_CR95","doi-asserted-by":"publisher","first-page":"12962","DOI":"10.1021\/acsanm.2c02782","volume":"5","author":"R Joshi","year":"2022","unstructured":"Joshi R, Patra S, Srivastava M, Singh BP, Chakraborty A, Shelar SB, Chakravarty R, Chakraborty S, Ningthoujam RS. Mesoporous NaGdF4\/Ho\u2013Yb@m-SiO2 upconversion nanophosphors as a potent theranostic probe. ACS Appl Nano Mater. 2022;5(9):12962\u201371.","journal-title":"ACS Appl Nano Mater"},{"issue":"8","key":"3020_CR96","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.1021\/acs.molpharmaceut.2c00182","volume":"19","author":"A Cytryniak","year":"2022","unstructured":"Cytryniak A, \u017belechowska-Matysiak K, Nazaruk E, Bilewicz R, Walczak R, Majka E, Mames A, Bruchertseifer F, Morgenstern A, Bilewicz A, Majkowska-Pilip A. Cubosomal lipid formulation for combination cancer treatment: delivery of a chemotherapeutic agent and complexed \u03b1-particle emitter 213Bi. Mol Pharm. 2022;19(8):2818\u201331.","journal-title":"Mol Pharm"},{"issue":"4","key":"3020_CR97","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.3390\/molecules28041864","volume":"28","author":"MEN Elghobary","year":"2023","unstructured":"Elghobary MEN, Munekane M, Mishiro K, Fuchigami T, Ogawa K. Preparation and evaluation of thermosensitive liposomes encapsulating I-125-labeled doxorubicin derivatives for auger electron therapy. Molecules. 2023;28(4):1864.","journal-title":"Molecules"},{"key":"3020_CR98","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.nucmedbio.2021.03.001","volume":"96\u201397","author":"KL Madsen","year":"2021","unstructured":"Madsen KL, Therkelsen ASN, Langkj\u00e6r N, Olsen BB, Thisgaard H. Auger electron therapy of glioblastoma using [125I]5-iodo-2\u2019-deoxyuridine and concomitant chemotherapy \u2013 Evaluation of a potential treatment strategy. Nucl Med Biol. 2021;96\u201397:35\u201340.","journal-title":"Nucl Med Biol"},{"issue":"10","key":"3020_CR99","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1038\/s41551-022-00949-4","volume":"6","author":"JL Schaal","year":"2022","unstructured":"Schaal JL, Bhattacharyya J, Brownstein J, Strickland KC, Kelly G, Saha S, Milligan J, Banskota S, Li X, Liu W, Kirsch DG, Zalutsky MR, Chilkoti A. Brachytherapy via a depot of biopolymer-bound 131I synergizes with nanoparticle paclitaxel in therapy-resistant pancreatic tumours. Nat Biomed Eng. 2022;6(10):1148\u201366.","journal-title":"Nat Biomed Eng"},{"issue":"5","key":"3020_CR100","doi-asserted-by":"publisher","first-page":"2200224","DOI":"10.1002\/adtp.202200224","volume":"6","author":"H Liu","year":"2023","unstructured":"Liu H, Nadar RA, Fauzia RP, Laan AC, Doeswijk B, Wang R, van de Meer A, van Cooten Q, Carroll ECM, Eelkema R, Denkova AG. Combined chemoradionuclide therapy using Poly(\u03b5-caprolactone-b-ethylene oxide) micelles as the delivery vehicle. Adv Ther. 2023;6(5):2200224.","journal-title":"Adv Ther"},{"issue":"29","key":"3020_CR101","doi-asserted-by":"publisher","first-page":"4738","DOI":"10.1039\/C8TB01295D","volume":"6","author":"D Zheng","year":"2018","unstructured":"Zheng D, Liu K, Zhao J, Tao Y, Wang Y, He J, Lei J, Xi X. pH-Sensitive nanogels based on the electrostatic self-assembly of radionuclide 131I labeled albumin and carboxymethyl cellulose for synergistic combined chemo-radioisotope therapy of cancer. J Mater Chem B. 2018;6(29):4738\u201346.","journal-title":"J Mater Chem B"},{"issue":"21","key":"3020_CR102","doi-asserted-by":"publisher","first-page":"5570","DOI":"10.3390\/cancers13215570","volume":"13","author":"A Rondon","year":"2021","unstructured":"Rondon A, Rouanet J, Degoul F. Radioimmunotherapy in oncology: overview of the last decade clinical trials. Cancers. 2021;13(21):5570.","journal-title":"Cancers"},{"issue":"17","key":"3020_CR103","doi-asserted-by":"publisher","first-page":"3652","DOI":"10.1158\/1078-0432.CCR-21-4332","volume":"28","author":"SC Kleinendorst","year":"2022","unstructured":"Kleinendorst SC, Oosterwijk E, Bussink J, Westdorp H, Konijnenberg MW, Heskamp S. Combining targeted radionuclide therapy and immune checkpoint inhibition for cancer treatment. Clin Cancer Res. 2022;28(17):3652\u20137.","journal-title":"Clin Cancer Res"},{"key":"3020_CR104","doi-asserted-by":"publisher","first-page":"151837","DOI":"10.1016\/j.cej.2024.151837","volume":"490","author":"H Shen","year":"2024","unstructured":"Shen H, Chen S, Zhang C, Liu T, Tao Y, Hu L, Yang K. Engineered delivery platform based on bacterial outer membrane vesicles for efficient labeling of 131I and improved radio-immunotherapy. Chem Eng J. 2024;490:151837.","journal-title":"Chem Eng J"},{"issue":"9","key":"3020_CR105","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.2967\/jnumed.116.188789","volume":"58","author":"Y Nakamura","year":"2017","unstructured":"Nakamura Y, Nagaya T, Sato K, Okuyama S, Ogata F, Wong K, Adler S, Choyke PL, Kobayashi H. Cerenkov radiation-induced photoimmunotherapy with (18)F-FDG. J Nucl Med. 2017;58(9):1395\u2013400.","journal-title":"J Nucl Med"},{"issue":"4","key":"3020_CR106","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.matt.2019.07.007","volume":"1","author":"L Tian","year":"2019","unstructured":"Tian L, Wang Y, Sun L, Xu J, Chao Y, Yang K, Wang S, Liu Z. Cerenkov luminescence-induced NO release from 32P-Labeled ZnFe(CN)5NO nanosheets to enhance radioisotope-immunotherapy. Matter. 2019;1(4):1061\u201376.","journal-title":"Matter"},{"issue":"4","key":"3020_CR107","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1039\/C9MH01725A","volume":"7","author":"W Su","year":"2020","unstructured":"Su W, Chen C, Wang T, Li X, Liu Y, Wang H, Zhao S, Zuo C, Sun G, Bu W. Radionuclide-labeled gold nanoparticles for nuclei-targeting internal radio-immunity therapy. Mater Horiz. 2020;7(4):1115\u201325.","journal-title":"Mater Horiz"},{"key":"3020_CR108","doi-asserted-by":"publisher","first-page":"101144","DOI":"10.1016\/j.nantod.2021.101144","volume":"38","author":"P Pei","year":"2021","unstructured":"Pei P, Shen W, Zhou H, Sun Y, Zhong J, Liu T, Yang K. Radionuclide labeled gold nanoclusters boost effective anti-tumor immunity for augmented radio-immunotherapy of cancer. Nano Today. 2021;38:101144.","journal-title":"Nano Today"},{"issue":"5","key":"3020_CR109","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s40846-022-00715-6","volume":"42","author":"C-C Chen","year":"2022","unstructured":"Chen C-C, Chan Y-H, Lin S-L, Chiang HK, Lee Y-J, Chuang H-Y. Theranostic Radiolabeled Nanomaterials for Molecular Imaging and potential Immunomodulation Effects. J Med Biol Eng. 2022;42(5):555\u201378.","journal-title":"J Med Biol Eng"},{"issue":"1","key":"3020_CR110","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s40824-022-00290-6","volume":"26","author":"J Zhang","year":"2022","unstructured":"Zhang J, Li F, Yin Y, Liu N, Zhu M, Zhang H, Liu W, Yang M, Qin S, Fan X, Yang Y, Zhang K, Yu F. Alpha radionuclide-chelated radioimmunotherapy promoters enable local radiotherapy\/chemodynamic therapy to discourage cancer progression. Biomater Res. 2022;26(1):44.","journal-title":"Biomater Res"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-024-03020-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-024-03020-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-024-03020-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T13:02:57Z","timestamp":1732280577000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-024-03020-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,22]]},"references-count":110,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3020"],"URL":"https:\/\/doi.org\/10.1186\/s12951-024-03020-3","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,22]]},"assertion":[{"value":"12 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"We confirm that the details of any images can be published. Copyright permission is granted.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"728"}}